July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Ocular Safety of AAV2.7m8-ChrimsonR-tdTomato (GS030-DP) following intravitreous injection and exposure to 595 nm LED light in blind rd1 mice
Author Affiliations & Notes
  • Brian J Christian
    Covance Laboratories, Inc, Madison, Wisconsin, United States
  • Steven D Sorden
    Covance Laboratories, Inc, Madison, Wisconsin, United States
  • Michael Ward
    Covance Laboratories, Inc, Madison, Wisconsin, United States
  • T Michael Nork
    Ocular Services On Demand, Madison, Wisconsin, United States
  • Paul E Miller
    Ocular Services On Demand, Madison, Wisconsin, United States
  • Anne Douar
    GenSight Biologics, Paris, France
  • Nitza Thomasson
    GenSight Biologics, Paris, France
  • Celine Bouquet
    GenSight Biologics, Paris, France
  • Footnotes
    Commercial Relationships   Brian Christian, None; Steven Sorden, None; Michael Ward, None; T Nork, None; Paul Miller, None; Anne Douar, GenSight Biologics (E); Nitza Thomasson, GenSight Biologics (E); Celine Bouquet, GenSight Biologics (E)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 5658. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Brian J Christian, Steven D Sorden, Michael Ward, T Michael Nork, Paul E Miller, Anne Douar, Nitza Thomasson, Celine Bouquet; Ocular Safety of AAV2.7m8-ChrimsonR-tdTomato (GS030-DP) following intravitreous injection and exposure to 595 nm LED light in blind rd1 mice. Invest. Ophthalmol. Vis. Sci. 2018;59(9):5658.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : GS030-DP, AAV2.7m8 encoding ChrimsonR, an algal light-sensitive opsin, fused to tdTomato, converts retinal ganglion cells into photoactivatable cells and is intended to restore vision in retinitis pigmentosa patients. The objective of this study was to characterize the ocular toxicity of GS030-DP in a relevant animal model following transgene product expression and exposure to the 595 nm LED light required for opsin activation.

Methods : Groups of rd1 (C3H/HeNCrL) mice (5 to 7 weeks old) received either vehicle or GS030-DP [7.84 x 109 vector genomes (vg)/eye] by intravitreous injection (1μL/eye) to both eyes. After 5 weeks post injection, subgroups (6/sex) within each treatment group were anesthetized and exposed to either room light or pulsed (0.81 Hz) 595 nm LED light at 1.4x1016 or 1.7x1017 photons/cm2/s (using a purpose-built illumination device). Animals were monitored for 2 weeks following light exposure after which they were euthanized. Eyes were examined microscopically for the presence of ChrimsonR-tdTomato and morphological changes.

Results : Minimal to marked ChrimsonR-tdTomato immunolabeling was demonstrated in retinas of all GS030-DP animals, and was generally characterized by multifocal staining of cell processes in the inner plexiform and nerve fiber layers and perikarya in the ganglion cell layer. Minimal to moderate ChrimsonR staining was also observed in axons of optic nerves. No GS030-DP-related findings were observed upon slit-lamp biomicroscopic or indirect ophthalmoscopic examination and no LED light-related retinal findings were noted at either light intensity. Following the light exposure period, cataract and corneal findings (edema, vascularization, ulcer) were noted in vehicle control and GS030-DP treated groups exposed to room or LED lighting conditions, and were considered secondary to the light exposure procedure (anesthesia, mydriatic, lubricant). Microscopic evaluation did not identify GS030-DP-related findings in the eyes or optic nerves, and no LED light related findings were identified in the retina.

Conclusions : Intravitreous GS030-DP at 7.84 x 109 vg/eye was well-tolerated in rd1 mice and its expression combined with 595 nm LED light exposure was not associated with toxicity in retina or optic nerve.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×